Condition: Metastatic Non-small Cell Lung Cancer · Sponsor: Necmettin Erbakan University
The aim of this study is to evaluate the effect of a probiotic supplement containing Bifidobacterium animalis lactis BL-04 on the clinical effectiveness of immunotherapy in patients diagnosed with metastatic non-small cell lung cancer who are receiving immunotherapy.
This description comes directly from the study's public registry record.
Mehmet Artaç, MD · +90332236000 · martac@erbakan.edu.tr
Always discuss trial participation with your own doctor first.
| Necmettin Erbakan University | Konya, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06428422